1Pembrolizumab: a new PD-1 inhibitor as first-line therapy for non-small cell lung cancerZHANG Jing-ru, ZHAO Li-bo, GU Jian969-9722Budget impact analysis of icotinib for terminal non-small cell lung cancerLUO Xue-yan, YUAN Quan, YAO Wen-bing973-9773Binary drug protection in China and reformation on Chinese pharmaceutical patent linkage systemDOU Xia-rui, WU Rang-feng978-9834A review on formulation and preparation of dry powder inhaler drug productsGAO Lei, MA Yu-nan, WANG Ya-min, NING Li-li, YAO Fang-yao984-9875Advances in the strategies to enhance oral drug absorption for achlorhydric patientsFU Zhong-hua, LIU Mei, WANG Xiao-ke, FAN Yun-zhou, WANG Ai-feng, GAO Chun-sheng988-9936The improvement of testing standards about related substances of piperacillin sodium and sulbactam sodium for injectionGAO Liang, ZHANG Yu-ying, SUN Ming-jie, WANG Ting994-9997Drug polymorphic transformation during manufacturing process of solid dosage formsGAO Jing, TENG Zai-jin, SHU Jian-hui, JIANG Shu-guang1000-10058A tolerance trial of extract of rhizoma gastrodiae in Chinese healthy subjectsLI Rui, ZHAO Ying-pan, GAO Hong-yang, WANG Shu-ge, LI Bo, ZI Ming-jie, HOU Jin-ru, ZHAO Yang, LI Qing-na, CAO Wei-yi, GAO Rui1006-10119A multi-center clinical evaluation trial of Fufang Qinlan Oral Liquid in the treatment of cold (acute upper respiratory tract infection) with external invaded wind heat syndromeSHI Cun-zhong, ZHEN Hui, LIU Xin-qiao1012-101810Sample sizes of reference-scaled average bioequivalence for highly variable drugs: implementation of FDA approachYU Yong-pei, YAN Xiao-yan, YAO Chen, XIA Jie-lai1019-102411Design and evaluation of clinical exposure-response researchYIN Fang, HUANG Ji-han, YANG Juan, HE Ying-chun, ZHENG Qing-shan1025-102912Survey and ethical consideration of old people participating clinical drug trialsFENG Long-fei1030-103313Interaction between Danhong injection and aspirin based on human liver microsome CYP1A2LI Xue-lin, ZHANG Fan, LI Wei-xia, CAO Ying-jie, WANG Xiao-yan, ZHANG Shu-qi, TANG Jin-fa1034-103914Correlation between effective components in processed products of Polygonum multiflorum Thunb and their anti-aging efficacyLI Xue-lin, ZHANG Fan, TANG Jin-fa, LI Wei-xia, CAO Ying-jie, WANG Xiao-yan1040-104615Synthesis of the novel fluorescent false neurotransmitter FFN200FAN Wen-hao, NI Luo-fan, SHI Jia-wei, QIN Ya-juan, LI Ting-you1047-105116Pharmacokinetics of rabeprazole thioether after multiple doses in ratsWANG Ben-wei, LIU Lin, WANG Fang, LU Hai-yan, JIA Qing-wen, QI Min1052-105717Stability of rosuvastatin calcium and rosuvastatin lactoneTONG Xue, SUN Hong-zhang, L(U) Hui-xia1058-106418Comprehensive evaluation of TLC system for quality control of Niuhuang Zhenjing pillsYAO Ling-wen, LIU Yan, ZHENG Xiao-wei, DAI Zhong, WANG Qi, MA Shuang-cheng1065-106919Culture of oligodendrocyte precursor cells and development of myelination model for drug screeningWANG Lu, YANG Han-yu, ZANG Cai-xia, ZHU Hai-bo, BAO Xiu-qi, ZHANG Dan1070-107520Extraction technology of sennoside A and B from SennaHU Jun, YANG Jing, BI Hai-lin, SU Ling, XIAO Yu-zhang, TANG Jian-hua1076-1082 